Advertisement
Persons > All
Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.Total search results: 4964 | Ordered by Person (ascending)
1 2 3 ... 48 49 50
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Watkins, H. Thomas (HGSI 200512 CEO) | Chief Executive Officer (CEO) | GSK (Group) | Maryland (federal state) |
Watson, Dave (Univ Strathclyde 201003 Prof + ScotMet) | Professor | University of Strathclyde (Glasgow) | Scotland |
Watson, David (Lhasa Ltd 201302 CEO) | Chief Executive Officer (CEO) | Lhasa Ltd. | Yorkshire and the Humber (region) |
Watson, Lorna (Northbank Communications 200608 Senior Account Manager) | n. a. | Instinctif Partners (Group) | Greater London (region) |
Watson, Michael (VaxEquity 202109 Executive Chairman) | Board member, executive | VaxEquity Ltd. (VXT) | East of England (region) |
Watson, Nicola (Schauenburg 201412 at Markes international) | n. a. | Schauenburg (Group) | Wales |
Watson, Tim (Instinctif Partners 201807) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | NodThera Ltd. | East of England (region) |
Watt, Fiona (Univ Cambridge 201203 Professor of Molecular Genetics) | Professor | University of Cambridge | East of England (region) |
Watts, Richard (Qiagen 201004– Director Pharma Business Development before Pharma Regional Marketing Manager) | Business Development Manager / Strategy Manager | Qiagen (Group) | Nordrhein-Westfalen (federal state) |
Watts, Ryan (Denali Therapeutics 201608 CEO) | Chief Executive Officer (CEO) | Denali Therapeutics (Group) | California (federal state) |
Watts, Sam (Stratophase 201110 Business Development + Commercial Officer + co-founder) | Business Development Manager / Strategy Manager | Stratophase Ltd. | South East England (region) |
Watts, Tim (Oxford BioMedica 2012–201709 CFO RETIRED 9/17) | Chief Financial Officer (CFO) | Oxford Biomedica (Group) | South East England (region) |
Weaver, Aaron (Apeiron Investment 202110 Principal) | Principal (venture capital) | ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) | Malta_o |
Weaver, Richard (XenoGesis 201109– Managing Director + Founder before AstraZeneca R&D) | Managing Director | Sygnature Discovery (Group) | East Midlands (region) |
Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice) | Chief Executive Officer (CEO) | Congenica (Group) | East of England (region) |
Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) | Chief Executive Officer (CEO) | EKF Diagnostics (Group) | Greater London (region) |
Webb, Mike (Delta Diagnostics (UK) 201310– Operations Director + Co-owner before Hologic + Gen-Probe + Tepnel) | General Manager (management) | Yourgene Health (Group) | North West England (region) |
Webber, Guy (Quotient Bioresearch 201003 Head of In Vitro Sciences) | n. a. | Quotient Bioresearch (Group) | East of England (region) |
Weber, Christophe (Takeda 201504– CEO joined as COO 4/14 before GSK 201305 President GSK Vaccines) | Chief Executive Officer (CEO) | Takeda (Group) | Kinki (region) |
Weber, Olaf (Bayer 201910 Head Radiology RnD) | n. a. | Bayer (Group) | Nordrhein-Westfalen (federal state) |
Wedlake, Bill (NextPharma 200301– CEO before CFO since 7/00) | Chief Executive Officer (CEO) | NextPharma (Group) | South East England (region) |
Weedon, Dimitrios (OrbiMed 202305– Managing Director in new London Office) | Managing Director | OrbiMed (Group) | Greater London (region) |
Wei, Liangshen (Horizon Discovery 201611 Head of Emerging Markets Team) | Business Development Manager / Strategy Manager | PerkinElmer (Group) | East of England (region) |
Weikert, Gunnar (Inventages Venture Capital 201609 Founder) | Company Founder | Inventages Venture Capital Investments Inc. | Région Lémanique (region) |
Weinberger, Paul (Lumora 201005– Chief Marketing Officer before Roche Diagnostics + Enigma Diagnostics) | Sales Manager / Marketing Manager | Erba Diagnostics Mannheim (Group) | East of England (region) |
Weinstein, Edward (Horizon Discovery 201607 President of Services Business) | President/Director/Head Business Group/Unit/Division | PerkinElmer (Group) | East of England (region) |
Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983) | Chief Executive Officer (CEO) | Sosei (Group) | East of England (region) |
Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) | Chief Executive Officer (CEO) | Sitryx Therapeutics Ltd. | South East England (region) |
Weiss, Andrew C. (Idorsia 201706– SVP + Head Investor Relations + Corporate Communications before Actelion) | Public Relations Manager / Investor Relations Manager | Idorsia (Group) | Northwestern Switzerland (region) |
Weiss, Jim (Real Chemistry 202201– Board Chair before CEO + Founder since 2001) | Board member, non-executive | Real Chemistry (WeissComm Group) (Group) | New York (federal state) |
Weisswasser, Sigal (T.B.N. Group 201201 President + Founder) | President/Director/Head Business Group/Unit/Division | T.B.N. Group (Technology Business Networks) (Group) | Israel_o |
Wells, Glenn (Wellcome Trust 200809 BusDev Manager) | Business Development Manager / Strategy Manager | Wellcome Trust, The | Greater London (region) |
Welsh, Chris (Consilium Strategic Communications 201707) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
Welten, Harry (Cytos Biotechnology 201203 CFO) | Chief Financial Officer (CFO) | Kuros (Group) | Zürich (region) |
Wentworth, James (Transgene 202401– CBO before Adaptimmune + inVentiv Health + Shire + ViroPharma) | Chief Business Officer (CBO) | Mérieux (Group) | Grand Est (Great East) (region) |
Werner, Thomas (Board Member of several companies before GSK SVP) | Board member, non-executive | GSK (Group) | Greater London (region) |
Wertz, Brad (GenomOncology 202208 CEO) | Chief Executive Officer (CEO) | GenomOncology LLC (GO) | Ohio (federal state) |
Wessels, Alexander (DSM 201210 CEO of DSM Pharmaceutical Products) | Chief Executive Officer (CEO) | DSM (Group) | Netherlands_o |
West, Stuart (Biocatalysts Ltd 201803 Managing Director) | Managing Director | BRAIN Biotech (Group) | Wales |
West, Will (CellCentric –200710– CEO + Morningside Ventures 202109) | Chief Executive Officer (CEO) | CellCentric Ltd. | East of England (region) |
Westby, Mike (Agalimmune 201406 CEO) | Chief Executive Officer (CEO) | BioLineRx (Group) | Greater London (region) |
Wester, Per (Alzinova 201601 CEO) | Chief Executive Officer (CEO) | Alzinova AB (publ) | Västra Götaland |
Weston, Nick (Agenix 201308 CEO) | Chief Executive Officer (CEO) | Agenix (Group) | Australia_ooo |
Westphal, Christopher (Sirtris 200603 CEO + co-founder before Alnylam CEO + co-founder + Momenta CEO + co-founder) | Chief Executive Officer (CEO) | GSK (Group) | Massachusetts (federal state) |
Westrop, Rod (Axordia 200610 Commercial Director) | n. a. | Axordia Ltd. | Yorkshire and the Humber (region) |
Wetekam, Volker (General Electric 201205– CEO + President of GE Healthcare Germany before AGFA HealthCare + Siemens) | Chief Executive Officer (CEO) | General Electric (Group) | South East England (region) |
Wetzel, Bernd (SR Pharma 200507 non-executive Director) | Board member, non-executive | Silence Therapeutics (Group) | Greater London (region) |
Wheeler, Alannah (Biosynth 202309 Marketing) | Sales Manager / Marketing Manager | Biosynth (since 9/22) (Group) | Switzerland_other |
Wheeler, Jeremy (BioCaptiva 202204– CEO) | Chief Executive Officer (CEO) | BioCaptiva Ltd. | Scotland |
Wheeler, Patrick (ACD/Labs 201408 NMR Product Manager) | Product Manager (personnel) | Advanced Chemistry Development (ACD/Labs) (Group) | Ontario |
Wheeler, Paul (Lumicks 202107– CCO before Luminex + Merck + PRW Bioscience + Singulex + Gyros + Guava Technologies) | Chief Commercial Officer (CCO) | Lumicks (Group) | North Holland (province, NL) |
Whelan, Kate (Notch Communications 201108 COO) | Chief Executive Officer (CEO) | Notch Communications AB | Uppsala (region) |
Whetton, Tony (Univ Manchester 201510 Prof + Director of Stoller Biomarker Discovery Center) | Professor | University of Manchester (UoM) | North West England (region) |
Whileman, David (Inflexion 202301 Head of Partnership Capital) | Investment Manager | Inflexion (Group) | Greater London (region) |
Whitaker, Paul (Biosilta 201604 Managing Director) | Managing Director | BioSilta (Group) | East of England (region) |
Whitcombe, David (Dxs 200812 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Qiagen (Group) | North West England (region) |
White, Amanda (Health Data Research UK 201807 Director of Communications + Marketing) | Public Relations Manager / Investor Relations Manager | Health Data Research UK | Greater London (region) |
White, Colin (Perceptive Instruments 201311 Managing Director) | Managing Director | Instem (Group) | East of England (region) |
White, James (Osmetech 200511 CEO) | Chief Executive Officer (CEO) | Roche (Group) | Greater London (region) |
White, Janet (Lonza 201109 Head Development Services) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
White, Miles D. (Abbott 200611 CEO) | Chief Executive Officer (CEO) | Abbott (Group) | Illinois (federal state) |
Whitehead, Carlene (Danaher 201204 European MarCom Specialist at Molecular Devices UK) | Public Relations Manager / Investor Relations Manager | Danaher (Group) | South East England (region) |
Whitehead, Stephen (ABPI 201211 Chief Executive) | Chief Executive Officer (CEO) | ABPI (Association of the British Pharmaceutical Industry) | Greater London (region) |
Whitehurst, Peter (Arcis:Altos 201810 CEO of Arcis Biotechnology) | Chief Executive Officer (CEO) | Arcis:Altos (Group) | North West England (region) |
Whiteley, Nick (European Spectrometry Systems founder) | Company Founder | European Spectrometry Systems Ltd. (ESS) | North West England (region) |
Whitley, Graeme (Wiley 201607 Director New Business Development) | Business Development Manager / Strategy Manager | Wiley (Group) | New Jersey (federal state) |
Whitmire, Jason D. (BY Capital 201509– Managing Director) | Managing Partner (investment firm) | BY Capital (BlueYard Capital) (Group) | Berlin (federal state) |
Whitmore, Terry (Henniker Scientific 200901– founder) | Company Founder | Henniker Scientific Ltd. | North West England (region) |
Whittingham, Jerel (Myconostica 200804 CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | North West England (region) |
Whittley, Nadia (Arquer Diagnostics 201612– CEO before Tefen Management Consulting + Alium Medical + Allergan) | Chief Executive Officer (CEO) | Arquer Diagnostics Ltd. | North East England (region) |
Whyatt, Fiona (Ramarketing 202211) | Public Relations Manager / Investor Relations Manager | Ramarketing (Group) | North East England (region) |
Wicks, Jim (PrimerDesign Ltd 201201 Managing Director) | Managing Director | Novacyt (Group) | South East England (region) |
Widdowson, Caroline (Schauenburg 201412 promoted Produt Marketing Manager Thermal Desorption at Markes) | Sales Manager / Marketing Manager | Schauenburg (Group) | Wales |
Widdowson, Peter S. (Quethera 201808 CEO) | Chief Executive Officer (CEO) | Astellas (Group) | East of England (region) |
Widmann, Rudolf (AOP Orphan Pharmaceuticals AG 201110 CEO) | Chief Executive Officer (CEO) | Élan (Group) | Wien (state) |
Widmann, Thomas | n. a. | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
Wiederhold, Bob (Synthace 202105 Board Chairman) | Board member, non-executive | Synthace (Group) | Greater London (region) |
Wiedow, Oliver (Proteo Biotech 201411 Director of Proteo Inc) | President/Director/Head Business Group/Unit/Division | Proteo Biotech (Group) | California (federal state) |
Wiener, Albrecht (Eppendorf UK 200704 Managing Director) | Managing Director | Eppendorf (Group) | East of England (region) |
Wiesel, Philippe (AgomAb Therapeutics 202103– CMO before Genkyotex + Serono in US + CH) | Chief Medical Officer (CMO) | Calliditas Therapeutics (Group) | Région Lémanique (region) |
Wigerinck, Piet (Galapagos 201304 CSO before SVP Developm before Tibotec) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Galapagos (Group) | Flanders (Flemish region) |
Wight, Andy (Danaher 201406 Director Service Product Portfolio at AB Sciex) | n. a. | Danaher (Group) | Massachusetts (federal state) |
Wiinberg, Ulf (Lundbeck 200806–201411 CEO before Wyeth RESIGNED 11/14) | Chief Executive Officer (CEO) | Lundbeck (Group) | Hovedstaden |
Wilcock, Iain (200811– BPCE Investment Advisor to Seventure Partners + Vela Ventures before Quester) | n. a. | BPCE (Group) | Île-de-France (region) |
Wilcockson, Mark (United Kingdom (govt) 202210 at British Business Bank) | Investment Manager | Mercia (Group) | United Kingdom (state/region unspecified) |
Wildauer, Kate (SynBioBeta LLC 201702 CEO) | Chief Executive Officer (CEO) | SynBioBeta LLC | California (federal state) |
Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder) | Chief Business Officer (CBO) | Compass Pathways (Group) | North West England (region) |
Wiley, Joseph (Joe) (Amryt Pharma 201912 CEO) | Chief Executive Officer (CEO) | Amryt Pharma (Group) | Ireland (cl4) |
Wilkie, James (Univ Birmingham 201410 CEO of Alta Innovations) | Chief Executive Officer (CEO) | University of Birmingham | West Midlands (region) |
Wilkinson, Malcolm (Kirkstall 201802 CEO) | Chief Executive Officer (CEO) | Kirkstall (GB) | United Kingdom (state/region unspecified) |
Willcocks, Spike (Oxford NanoLabs 200702 Director of Business Development) | Business Development Manager / Strategy Manager | Oxford Nanopore (Group) | South East England (region) |
Willetts, David (United Kingdom (govt) 201205 Minister for Universities and Science) | Minister | United Kingdom (GB) (govt) | Greater London (region) |
Williams, Andrew (Halma 201011 CEO) | Chief Executive Officer (CEO) | Halma (Group) | South East England (region) |
Williams, Andrew (LabLogic Systems 200801– before Leeds University) | Sales Manager / Marketing Manager | LabLogic (Group) | Yorkshire and the Humber (region) |
Williams, Antony (RSC 200905– VP Strategic Development before ChemZoo 200804 President) | n. a. | Royal Society of Chemistry, The (RSC) | United Kingdom (state/region unspecified) |
Williams, David (Nanna Therapeutics 202004 CEO before Discuva) | Chief Executive Officer (CEO) | Astellas (Group) | East of England (region) |
Williams, Doris-Ann (BIVDA 200705 Director General) | General Manager (management) | BIVDA (British In Vitro Diagnostic Regulatory Association) | Greater London (region) |
WIlliams, Jeff (Clinipace 201504 CEO) | Chief Executive Officer (CEO) | Clinipace (Group) | North Carolina (federal state) |
Williams, Jon (Aquapharm Biodiscovery 201207 VP Commercial) | Chief Commercial Officer (CCO) | Aquapharm Biodiscovery Ltd. | Scotland |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top